Literature DB >> 7213528

Comparative pharmacokinetics of theophylline and aminophylline in man.

A Aslaksen, O M Bakke, T Vigander.   

Abstract

1 The pharmacokinetics of theophylline and aminophylline was compared after oral administration and intravenous infusion. 2 Theophylline (250 mg) and aminophylline (390 mg) were taken orally by eight healthy volunteers in a randomized cross-over study. 3 In another cross-over study theophylline and aminophylline were administered intravenously to six healthy volunteers at a dose corresponding to 5 mg/kg pure theophylline. 4 The protein binding of the theophylline in serum collected during the intravenous study was studied by ultrafiltration. The serum concentration of theophylline was measured by high pressure liquid chromatography. 5 Almost identical concentration-time curves were found for theophylline and aminophylline in both of the studies. No significant difference was found in the pharmacokinetic parameters or protein binding with the two preparations.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7213528      PMCID: PMC1401615          DOI: 10.1111/j.1365-2125.1981.tb00533.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

Review 1.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

2.  Micro-scale method for theophylline in body fluids by reversed-phase, high-pressure liquid chromatography.

Authors:  J J Orcutt; P P Kozak; S A Gillman; L H Cummins
Journal:  Clin Chem       Date:  1977-03       Impact factor: 8.327

3.  Use of a programmable hand-held calculator for clinical pharmacokinetics.

Authors:  T S Foster; D W Bourne
Journal:  Am J Hosp Pharm       Date:  1977-01

4.  Contact dermatitis attributed to ethylenediamine.

Authors:  M I White; W S Douglas; R A Main
Journal:  Br Med J       Date:  1978-02-18

5.  A comparison of the metabolism and pharmacokinetics of intravenously administered theophylline and aminophylline in man [proceedings].

Authors:  J Caldwell; T J Monks; R L Smith
Journal:  Br J Pharmacol       Date:  1978-06       Impact factor: 8.739

6.  Absolute bioavailability of oral theophylline.

Authors:  L Hendeles; M Weinberger; L Bighley
Journal:  Am J Hosp Pharm       Date:  1977-05

7.  Theophylline disposition in patients with hepatic cirrhosis.

Authors:  K M Piafsky; D S Sitar; R E Rangno; R I Ogilvie
Journal:  N Engl J Med       Date:  1977-06-30       Impact factor: 91.245

8.  Ethylenediamine contact dermatitis.

Authors:  T T Provost; O F Jillson
Journal:  Arch Dermatol       Date:  1967-09

9.  Theophylline protein binding in humans.

Authors:  K J Simons; F E Simons; C J Briggs; L Lo
Journal:  J Pharm Sci       Date:  1979-02       Impact factor: 3.534

10.  Generalized exfoliative dermatitis from ethylenediamine.

Authors:  J W Petrozzi; R N Shore
Journal:  Arch Dermatol       Date:  1976-04
View more
  12 in total

1.  Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis.

Authors:  Sheila Annie Peters
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

2.  Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.

Authors:  Zufei Zhang; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2017-01-03       Impact factor: 3.922

3.  Do saliva concentrations predict plasma unbound theophylline concentrations? A problem re-examined.

Authors:  C Knott; M Bateman; F Reynolds
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

4.  Binding of theophylline in human serum determined by ultrafiltration and equilibrium dialysis.

Authors:  O Brørs; G Sager; D Sandnes; S Jacobsen
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

5.  Theophylline pharmacokinetics after intravenous infusion with ethylenediamine or sodium glycinate.

Authors:  J Caldwell; A H Staib; I A Cotgreave; M Siebert-Weigel
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

Review 6.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

Review 7.  Ethylenediamine, profile of a sensitizing excipient.

Authors:  J Zuidema
Journal:  Pharm Weekbl Sci       Date:  1985-08-23

Review 8.  Pharmacokinetic interactions of cimetidine 1987.

Authors:  A Somogyi; M Muirhead
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

9.  Are Physiologically Based Pharmacokinetic Models Reporting the Right C(max)? Central Venous Versus Peripheral Sampling Site.

Authors:  Helen Musther; Katherine L Gill; Manoranjenni Chetty; Amin Rostami-Hodjegan; Malcolm Rowland; Masoud Jamei
Journal:  AAPS J       Date:  2015-06-23       Impact factor: 4.009

Review 10.  Xanthine scaffold: scope and potential in drug development.

Authors:  Nivedita Singh; Ashwinee Kumar Shreshtha; M S Thakur; Sanjukta Patra
Journal:  Heliyon       Date:  2018-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.